Who Buys Vati from India — 869 Importers Behind a $26.3M Market

The importers of Vati from India can be categorized into several key segments:

1. Pharmaceutical Distributors: Entities such as AUROBINDO PHARMA USA INC and LIFESTAR PHARMA LLC in the United States, as well as MSK PHARMALOGISTIC GMBH in Germany, fall into this category. These distributors procure Vati in bulk to supply to various healthcare providers, pharmacies, and retailers. Their purchasing patterns typically involve large, regular orders to maintain a steady supply chain and meet consistent market demand.

2. Contract Manufacturers: Companies like MICRO LABS GMBH in Germany and AUROLOGISTICS LLC in the United States serve as contract manufacturers. They import Vati to incorporate into their own pharmaceutical products or to fulfill manufacturing contracts for other brands. Their procurement is often project-based, aligning with specific production schedules and client requirements.

3. Re-exporters: Entities such as EAST MIDLANDS PHARMA LTD in the United Kingdom may act as re-exporters, importing Vati to distribute to other countries. This segment's buying behavior is influenced by international demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

4. Government Procurement Agencies: Organizations like EMBASSY PHARMACEUTICAL AND in Nigeria are likely involved in government procurement. They import Vati to supply public health programs and hospitals, often through tender-based purchasing. Their orders are typically large and periodic, corresponding with government budget cycles and healthcare initiatives.

Overall, the repeat buyer rate of 64.4% indicates a stable demand across these segments, with distributors and contract manufacturers showing the most consistent purchasing patterns due to ongoing market needs and production schedules.

For the top five importing countries of Vati, the import regulations are as follows:

The demand for Vati in importing countries is driven by several factors:

1. Disease Prevalence: Vati is commonly used in the management of chronic conditions such as hypertension and diabetes. The increasing prevalence of these diseases globally has led to a higher demand for effective treatments. For instance, the World Health Organization reported in 2025 that approximately 1.13 billion people worldwide have hypertension, with a significant proportion residing in low- and middle-income countries.

2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs to provide broader access to essential medicines. The inclusion of Vati in national formularies and reimbursement schemes enhances its accessibility and affordability, thereby boosting demand.

3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Vati's inclusion in the World Health Organization's Essential Medicines List underscores its importance in primary healthcare. This inclusion often leads to bulk procurement by governments and international organizations through tender-based purchasing, ensuring a steady demand.

With 869 buyers across 141 countries, the market for Vati demonstrates a broad and diverse demand base. This widespread interest indicates significant market opportunities for suppliers, especially in regions with growing healthcare needs and expanding access to essential medicines.

The importers of Vati from India can be categorized into several key segments:

1. Pharmaceutical Distributors: Entities such as AUROBINDO PHARMA USA INC and LIFESTAR PHARMA LLC in the United States, as well as MSK PHARMALOGISTIC GMBH in Germany, fall into this category. These distributors procure Vati in bulk to supply to various healthcare providers, pharmacies, and retailers. Their purchasing patterns typically involve large, regular orders to maintain a steady supply chain and meet consistent market demand.

2. Contract Manufacturers: Companies like MICRO LABS GMBH in Germany and AUROLOGISTICS LLC in the United States serve as contract manufacturers. They import Vati to incorporate into their own pharmaceutical products or to fulfill manufacturing contracts for other brands. Their procurement is often project-based, aligning with specific production schedules and client requirements.

3. Re-exporters: Entities such as EAST MIDLANDS PHARMA LTD in the United Kingdom may act as re-exporters, importing Vati to distribute to other countries. This segment's buying behavior is influenced by international demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

4. Government Procurement Agencies: Organizations like EMBASSY PHARMACEUTICAL AND in Nigeria are likely involved in government procurement. They import Vati to supply public health programs and hospitals, often through tender-based purchasing. Their orders are typically large and periodic, corresponding with government budget cycles and healthcare initiatives.

Overall, the repeat buyer rate of 64.4% indicates a stable demand across these segments, with distributors and contract manufacturers showing the most consistent purchasing patterns due to ongoing market needs and production schedules.

For the top five importing countries of Vati, the import regulations are as follows:

The demand for Vati in importing countries is driven by several factors:

1. Disease Prevalence: Vati is commonly used in the management of chronic conditions such as hypertension and diabetes. The increasing prevalence of these diseases globally has led to a higher demand for effective treatments. For instance, the World Health Organization reported in 2025 that approximately 1.13 billion people worldwide have hypertension, with a significant proportion residing in low- and middle-income countries.

2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs to provide broader access to essential medicines. The inclusion of Vati in national formularies and reimbursement schemes enhances its accessibility and affordability, thereby boosting demand.

3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Vati's inclusion in the World Health Organization's Essential Medicines List underscores its importance in primary healthcare. This inclusion often leads to bulk procurement by governments and international organizations through tender-based purchasing, ensuring a steady demand.

With 869 buyers across 141 countries, the market for Vati demonstrates a broad and diverse demand base. This widespread interest indicates significant market opportunities for suppliers, especially in regions with growing healthcare needs and expanding access to essential medicines.